Pharmaceutical Anatomic Pathology Testing Services

Anatomic pathology focuses on analyzing the effects a potential NME (new molecular entity) or compound might have on a body's organs or tissue. Service providers typically offer technologies such as specialty staining, including fluorescent in situ hybridization (FISH)/in situ hybridization (ISH) and immunohistochemistry (IHC) and digital imaging supports studies. Multiplex immunofluorescence (IF) and IHC capabilities provide quantifiable data concerning the relationship between cells and their density in a specific area. Analysis of this high-content data allows comparison of pre- and post-treatment tissue to help assess and predict therapeutic efficacy in specific disease states or in specific patient populations.